By Sriparna Roy and Amina Niasse (Reuters) – Analysts and investors are awaiting details behind UnitedHealth Group (NYSE:UNH)’s 2025 outlook when it reports
By Jody Godoy (Reuters) – The U.S. Federal Trade Commission’s merger-busting, antitrust enforcement powers are coming under threat as conservatives look to harness
Republican Florida Sen. Marco Rubio is bracing himself for the hot seat as he prepares to sit through the often-arduous confirmation hearing
President-elect Donald Trump’s selection to be attorney general in his new administration faces the Senate Judiciary Committee on Wednesday morning at a
BERLIN (Reuters) – Germany can only hope for a tangible economic recovery once there is clarity on the economic, financial and geopolitical
By Gayatri Suroyo and Stefanno Sulaiman JAKARTA (Reuters) -Indonesia’s central bank unexpectedly cut policy rates on Wednesday, resuming its monetary easing to prop
By Sinead Cruise and Lawrence White LONDON (Reuters) – Britain’s banks are accepting smaller profit margins and bigger risks on UK mortgage lending
Investing.com – US stock futures are steady ahead of the publication of a crucial US inflation report and the release of quarterly earnings
By Lisa Baertlein and Ellen Zhang LOS ANGELES/BEIJING (Reuters) – U.S. imports from China finished the year strong after some companies stockpiled shipments
COPENHAGEN (Reuters) – Finland’s Nokia (HE:NOKIA) said on Wednesday it had signed a multi-year patent license agreement with Samsung (KS:005930) , for
Investing.com — Hays (LON:HAYS) on Wednesday in a stock exchange filing cautioned that its pre-exceptional operating profit for the first
PRAGUE (Reuters) – Global deliveries for Czech carmaker Skoda Auto, part of the Volkswagen (ETR:VOWG_p) Group, rose by 6.9% in 2024, to
Investing.com — IBES earnings per share (EPS) growth estimates for Q4 2024 have been sharply reduced to just 2% for Europe, compared
Investing.com — ASOS (LON:ASOS) on Wednesday announced plans to mothball its Atlanta distribution center in the second half of 2025, marking a
(Reuters) -Pfizer will sell shares worth 2.50 billion pounds ($3.05 billion) in Haleon, lowering its stake in the British consumer healthcare company
(Reuters) – European shares opened higher on Wednesday due to broad-based gains as bond yields took a breather ahead of a crucial
